Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Adagene Inc is a platform-driven, clinical-stage biotechnology company focused on the discovery and development of novel antibody-based cancer immunotherapies. The Company leverages computational biology to design and develop novel antibodies....
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Adagene (NASDAQ:ADAG) through any online brokerage.
Other companies in Adagene’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Adagene has a consensus price target of $8.40.
The stock price for Adagene (NASDAQ: ADAG) is $2.78 last updated .
There are no upcoming dividends for Adagene.
Adagene does not have any upcoming earnings scheduled.
There is no upcoming split for Adagene.
Adagene is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.